Related Experiment Videos
A new non-depolarizing myorelaxant with high activity and specificity
European Journal of Pharmacology
|July 9, 1982
Summary
Tercuronium exhibits potent curare-like neuromuscular blocking activity, exceeding tubocurarine and nearing pancuronium. It offers a favorable safety profile with pronounced antagonism by neostigmine and minimal cardiovascular effects.
Area of Science:
- Pharmacology
- Neuromuscular Pharmacology
Background:
- Neuromuscular blocking agents are crucial in anesthesia and critical care.
- Understanding the specific properties of agents like tercuronium is essential for clinical application.
Purpose of the Study:
- To investigate the curare-like activity and mode of action of tercuronium.
- To compare tercuronium's efficacy and safety with existing neuromuscular blockers.
Main Methods:
- Experiments were conducted on cats, rabbits, mice, pigeons, and rat phrenic diaphragm preparations.
- Neuromuscular blocking doses (ED95) were determined.
- Antagonism by neostigmine and effects on cardiovascular parameters and autonomic ganglia were assessed.
Main Results:
- Tercuronium demonstrated higher curare-like activity than tubocurarine, comparable to pancuronium.
- Its onset and duration of action were similar to tubocurarine and pancuronium.
- Tercuronium showed pronounced neostigmine antagonism, no significant cardiovascular effects at blocking doses, and no initial blockade of autonomic ganglia.
Conclusions:
- Tercuronium is a potent, non-depolarizing myorelaxant with high neuromuscular blocking activity.
- It is distinguished by its specificity and enhanced neostigmine antagonism compared to tubocurarine.
- Tercuronium possesses a favorable safety profile regarding cardiovascular and autonomic effects.